Healthcare Market Research Reports

Pharmaceutical drug discovery and development processes suffer from declining success rates and a stagnant pipeline. Artificial Intelligence (AI) supported by Big Data could be a key element that can provide an effectual solution. There has been a rapid growth in the data generated within the life sciences and pharmaceutical industries. This stems ...

There are numerous companies developing immunotherapy approaches to treat cancer, autoimmune and several other diseases. Current study describes some of the recent advances in immunotherapy, mostly cancer. These include refined cell therapies, stem cell applications in cancer treatment, monoclonal, polyclonal and bispecific antibodies. Some of exci...

Therapeutically more effective drugs for the treatment of chronic diseases represents a crucial need. Biosimilars and biobetters offer the possibility to lower the cost of treating a variety of chronic diseases. In particular, biosimilars are the less expensive option; however, biobetters have demonstrated to be more effective, even over longer per...

At present, only a few therapies are available with relatively low success. Both, the clinical and the scientific communities are critically devoted to develop new therapeutic approaches to treat and diagnose neurodegenerative diseases. At present days, neurodegenerative diseases represent one of the main causes of death in the industrialized econ...

05 Sep 2019  |  Global  |  Market Research

Digital Transformation of the Global Medtech Industry, Forecast to 2024

Growth Opportunities to Boost Revenue in this Slowing Industry by an Additional $240 Billion by 2024

Infographics

×

Key Issues Addressed

The medtech industry’s revenue growth is expected to gradually dip beyond 2020, from a year-on-year growth of about 5.7Percentage in 2020 to 5.3Percentage in 2024. The industry is already addressing this as well as several other challenges such as the changing device ecosystem, shifting competitive focus, and the invasion by technology companies....

At present, only a few therapies are available with relatively low success. Both, the clinical and the scientific communities are critically devoted to develop new therapeutic approaches to treat and diagnose neurodegenerative diseases. At present days, neurodegenerative diseases represent one of the main causes of death in the industrialized econ...

This study examines the Turkish medical imaging market. Healthcare reforms focusing on oncology and cardiology as the priority areas has resulted in 80% of medical imaging equipment being purchased by the government. Frost & Sullivan estimates that revenue for computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound (USG) will rea...

Technology and design improvements in multipurpose R/F Systems, the recent increase in the adoption of fluoroscopy procedures by private healthcare facilities and commercialization of disruptive technologies in real-time R/F are set to boost growth opportunities in the Western European fluoroscopy market. These multi-functional R/F systems have the...

03 Jul 2019  |  Global  |  Market Research

Global Employee Health Management IT Market, Forecast to 2024

Well-Being and Corporate Performance are Top Priorities

Infographics

×

Key Issues Addressed

The purpose of this research service is to present a comprehensive analysis of the global employee health management information technology (EHM IT) market, with respect to how digital health platforms are expected to help employers devise and scale clinical and wellness programs that ensure employee well-being and improve organizational productivi...